Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Invested Capital (2024 - 2026)

Analysis

Biohaven (BHVN) Invested Capital (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Biohaven 2.37 Bn 2.10 Bn - 271.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 271.70 Mn
Mar 31, 2026 371.41 Mn
Dec 31, 2025 290.97 Mn
Sep 30, 2025 251.11 Mn
Jun 30, 2025 391.66 Mn
Dec 31, 2024 423.44 Mn